Chemical and Pharmaceutical Bulletin
Online ISSN : 1347-5223
Print ISSN : 0009-2363
ISSN-L : 0009-2363
Development of Potent and Selective Plasmin and Plasma Kallikrein Inhibitors and Studies on the Structure-Activity Relationship
Yoshio OKADAYuko TSUDAMayako TADAKeiko WANAKAUtako OKAMOTOAkiko HIJIKATA-OKUNOMIYAShosuke OKAMOTO
Author information
JOURNAL FREE ACCESS

2000 Volume 48 Issue 12 Pages 1964-1972

Details
Abstract
Based on structure-activity relationship studies, we designed and synthesized plasmin (PL) and plasma Kallikrein (PK) inhibitors. Trans-(4-aminomethylcyclohexanecarbonyl)-Tyr(O-Pic)-octylamide inhibited PL, PK, urokinase (UK) and thrombin (TH) with IC50 values of 0.53, 30 5.3 and >400μM, respectively. Trans-(4-aminomethylcyclohexanecarbonyl)-Tyr(O-2-Pyrim)-4-carboxyanilide inhibited PL, PK, UK and TH with IC50 values of 36, 0.56, 440 and >1000μM, respectively.
Content from these authors
© The Pharmaceutical Society of Japan
Previous article Next article
feedback
Top